Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.52
At close: May 12, 4:16 AM EDT
$9.48
-0.04-0.42%
Pre-Market: May 12, 4:16 AM EDT
Comments
Loading...
OptiNose (OPTN) Forecast
NewsEarningsOptiNose (OPTN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
OptiNose Stock Price, Quotes and Forecasts | NASDAQ:OPTN | Benzinga
Explore OptiNose stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OPTN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy OptiNose (OPTN) stock?
You can purchase shares of OptiNose (NASDAQ:OPTN) through any online brokerage.
Who are OptiNose (OPTN) competitors?
Other companies in OptiNose’s space includes: Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Universe Pharmaceuticals (NASDAQ:UPC), Neumora Therapeutics (NASDAQ:NMRA) and Aardvark Therapeutics (NASDAQ:AARD).
What is the forecast, or price target, for OptiNose (OPTN) stock?
OptiNose has a consensus price target of $7.40.
What is the current price for OptiNose (OPTN)?
The stock price for OptiNose (NASDAQ: OPTN) is $9.48 last updated May 12, 2025 at 4:16 AM EDT.
Does OptiNose (OPTN) pay a dividend?
There are no upcoming dividends for OptiNose.
When is OptiNose (NASDAQ:OPTN) reporting earnings?
OptiNose’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is OptiNose (OPTN) going to split?
There is no upcoming split for OptiNose.
What sector and industry does OptiNose (OPTN) operate in?
OptiNose is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
